220 related articles for article (PubMed ID: 17428389)
1. [Preparation and characterization of human colon tumor-associated antigen and its clinical significance].
Liu XY; Yao XL; Song Y; Liu XY; Zhang P; Xu ZS; Song LH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):335-7. PubMed ID: 17428389
[TBL] [Abstract][Full Text] [Related]
2. [Purification of colorectal cancer-associated antigen by immuno-affinity chromatography].
Yang Y; Li Y; Wang XH; Shang P; Wang L; Qian AR; Yao XY; Chen ZN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):348-51. PubMed ID: 15193236
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J
Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.
Hanski C; Hanski ML; Zimmer T; Ogorek D; Devine P; Riecken EO
Cancer Res; 1995 Feb; 55(4):928-33. PubMed ID: 7850810
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
[TBL] [Abstract][Full Text] [Related]
6. [Purification and characterization of corresponding antigen recognized by monoclonal antibody 183B2 against ovarian carcinoma].
Guo HF; Feng J; Zhang H; Yao Y; Cheng HY
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):614-8. PubMed ID: 16202318
[TBL] [Abstract][Full Text] [Related]
7. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
Katari RS; Fernsten PD; Schlom J
Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152
[TBL] [Abstract][Full Text] [Related]
9. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
Koestler TP; Papsidero LD; Nemoto T; Chu TM
Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
[TBL] [Abstract][Full Text] [Related]
10. Distribution of a squamous cell lung carcinoma-associated antigen, KA-32, in human tissues and sera defined by monoclonal antibody KM-32.
Hanai N; Shitara K; Yoshida H
Cancer Res; 1986 Oct; 46(10):5206-10. PubMed ID: 3530436
[TBL] [Abstract][Full Text] [Related]
11. Identification of a superficial bladder tumor-associated glycoform of the carcinoembryonic antigen by monoclonal antibody 19A211.
Bergeron A; LaRue H; Fradet Y
Cancer Res; 1996 Feb; 56(4):908-15. PubMed ID: 8631032
[TBL] [Abstract][Full Text] [Related]
12. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mucin antigens recognized by monoclonal antibodies raised against human colon cancer cells.
Fukui S; Horie T; Numata Y; Kitagawa H; Nakada H; Kawasaki T; Funakoshi I; Yamashina I
Cancer Res; 1991 Jan; 51(1):331-5. PubMed ID: 1988095
[TBL] [Abstract][Full Text] [Related]
14. Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line.
Tejuca M; Díaz I; Figueredo R; Roque L; Pazos F; Martínez D; Iznaga-Escobar N; Pérez R; Alvarez C; Lanio ME
Int Immunopharmacol; 2004 Jun; 4(6):731-44. PubMed ID: 15135315
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated antigen defined by a monoclonal antibody against neuraminidase-treated human cancer cells.
Ogasawara M; Takebe T; Ishii K
Cancer Res; 1988 Jan; 48(2):412-7. PubMed ID: 3422053
[TBL] [Abstract][Full Text] [Related]
16. High efficiency reconstitution of a human-mouse chimeric Fab of CAb-1 antibody specific to human colon cancer.
Yang XM; Xing JL; Liao CG; Yao XY; Li Y; Chen ZN
Scand J Immunol; 2008 Jul; 68(1):12-21. PubMed ID: 18482205
[TBL] [Abstract][Full Text] [Related]
17. Improved detection of the early stages of colon cancer by determining both free circulating and immune complex-bound antigens reactive with monoclonal antibody.
Chester SJ; Lim YP; Vezeridis MP; Hixson DC
Cancer Res; 1994 Aug; 54(15):3974-8. PubMed ID: 8033125
[TBL] [Abstract][Full Text] [Related]
18. The isolation of colon cancer organ specific neoantigen by the use of the leukocyte adherence inhibition assay and monoclonal antibodies.
Fink A; Harpaz N; Weisman Z; Shani A; Bentwich Z
Anticancer Res; 1986; 6(4):813-7. PubMed ID: 3752960
[TBL] [Abstract][Full Text] [Related]
19. Antigens associated with normal and malignant gastrointestinal tissues.
Goldenberg DM; Pant KD; Dahlman HL
Cancer Res; 1976 Sep; 36(9 PT 2):3455-63. PubMed ID: 975104
[TBL] [Abstract][Full Text] [Related]
20. Serological immunoreactivity against colon cancer proteome varies upon disease progression.
De Monte L; Sanvito F; Olivieri S; Viganò F; Doglioni C; Frasson M; Braga M; Bachi A; Dellabona P; Protti MP; Alessio M
J Proteome Res; 2008 Feb; 7(2):504-14. PubMed ID: 18179166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
